Filing Flows › Comparisons › BDPT vs PULM
Bioadaptives vs Pulmatrix: BDPT and PULM compared
Bioadaptives is the larger company: $5K of revenue in its latest quarter (Q2 2026) against $3K for Pulmatrix (Q4 2024). Bioadaptives is growing faster (+55% against -100% a year earlier).
Where the money goes: BDPT and PULM
Bioadaptives (BDPT) · Q2 2026
Bioadaptives, Q2 2026: revenue $5K (+55% year over year), net earnings $150K, operating cash flow −$44K. The chart follows the revenue to costs, profit and cash.
Pulmatrix (PULM) · Q4 2024
Pulmatrix, Q4 2024: revenue $3K (-100% year over year), net loss $2.0M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
| Bioadaptives (BDPT) | Pulmatrix (PULM) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q4 2024 |
| Revenue | $5K | $3K |
| Revenue growth, Y/Y | +55% | -100% |
| Operating margin | n/m | n/m |
| Net earnings | $150K | −$2.0M |
| Operating cash flow | −$44K | −$1.3M |
Questions
Which is bigger, Bioadaptives or Pulmatrix?
Bioadaptives is the larger company: $5K of revenue in its latest quarter (Q2 2026) against $3K for Pulmatrix (Q4 2024).
Is Bioadaptives or Pulmatrix growing faster?
Bioadaptives is growing faster (+55% against -100% a year earlier).
More: Bioadaptives earnings · how Bioadaptives makes money · Pulmatrix earnings · how Pulmatrix makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 19, 2026; 10-K filed Mar 21, 2025). Fiscal quarters can end on different dates. Not investment advice.